Quality statement 2: Stopping smoking
Adults with suspected or confirmed lung cancer who smoke receive evidence-based stop smoking support. [new 2019]
People with suspected or confirmed lung cancer who smoke should be encouraged to stop smoking to reduce the risk of treatment-related complications and other smoking-related conditions and increase their life expectancy. They should be provided with evidence-based support to help them to stop smoking.
Data source: Local data collection, for example, service protocols.
b) Evidence of local arrangements to provide evidence-based support for adults with suspected or confirmed lung cancer to help them to stop smoking.
Data source: Local data collection, for example, service specification and protocols.
Proportion of adults with suspected or confirmed lung cancer who smoke who receive evidence-based support to stop smoking.
Numerator – the number in the denominator who receive evidence-based support to stop smoking.
Denominator – the number of adults with suspected or confirmed lung cancer who smoke.
Data source: Royal College of Physicians National Lung Cancer Audit (measure in development). Data on smoking status and whether treatment for tobacco addiction was given from National Cancer Registration and Analysis Service Cancer Outcomes and Services Dataset.
a) Smoking rates in adults with lung cancer having treatment with curative intent.
b) 1-year survival rate for adults with lung cancer treated with curative intent.
Service providers (such as primary care, community services, secondary and tertiary care) ensure that processes are in place to provide advice to adults with suspected or confirmed lung cancer who smoke about why it is important to stop smoking. Providers ensure that they can provide evidence-based support to help people with suspected or confirmed lung cancer to stop smoking. This may also include referral pathways to evidence-based stop smoking support.
Healthcare professionals (such as GPs, pharmacists, clinical nurse specialists, consultants and radiographers) provide advice to adults with suspected or confirmed lung cancer who smoke about why it is important to stop smoking. They arrange for them to access evidence-based stop smoking support if they want to stop.
Commissioners (such as clinical commissioning groups, NHS England and local authorities) ensure that they commission services which provide evidence-based stop smoking support to adults with suspected or confirmed lung cancer who smoke.
Adults with suspected or confirmed lung cancer who smoke are told that it is important to stop smoking to avoid complications during treatment and prevent other smoking-related illnesses. They are told that stopping smoking may improve how long they live, and they are given help if they want to give up.
Lung cancer: diagnosis and management. NICE guideline NG122 (2019), recommendations 1.4.1, 1.4.2 and 1.4.3
Stop smoking interventions and services. NICE guideline NG92 (2018), recommendation 1.1.3
Smoking: acute, maternity and mental health services. NICE guideline PH48 (2013), recommendations 2, 3, 6, and 8
Adults with symptoms and signs of lung cancer who are referred for investigation.
The following interventions should be available:
behavioural support (individual and group)
nicotine replacement therapy – short and long acting
very brief advice.
[NICE's guideline on stop smoking interventions and services, recommendation 1.3.1 and terms used in this guideline and NICE's guideline on lung cancer, recommendation 1.4.3]
Information about stopping smoking should be in a format that suits the person's needs and preferences. It should be accessible to people who do not speak or read English, and it should be culturally appropriate. People should have access to an interpreter or advocate if needed. For people with additional needs related to a disability, impairment or sensory loss, information should be provided as set out in NHS England's Accessible Information Standard.